Literature DB >> 14759065

In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity.

F Santini1, P Vitti, G Ceccarini, C Mammoli, V Rosellini, C Pelosini, A Marsili, M Tonacchera, P Agretti, T Santoni, L Chiovato, A Pinchera.   

Abstract

Several natural or synthetic chemicals have been indicated as potential thyroid disruptors. The development of in vitro assays has been recommended to comprehensively assess the potential thyroid disrupting activity of a substance or a complex mixture. In this study, 12 substances suspected for acting as thyroid disruptors were tested for their ability to inhibit TSH-stimulated cAMP production in vitro. Those substances producing an inhibition were further studied to establish the level at which they interfere with this step of thyroid cell function. Using Chinese hamster ovary cells (CHO) transfected with the recombinant human TSH receptor, a dose-dependent inhibition of TSH-stimulated adenylate cyclase activity was produced by 1,1-bis-(4-chlorphenyl)-2,2,2-trichloroethan (DDT), Aroclor 1254 and Melissa Officinalis. All three substances also inhibited the cAMP production stimulated by TSH receptor antibody. Melissa Officinalis produced a significant inhibition of TSH binding to its receptor and of antibody binding to TSH, while no significant changes were produced by Aroclor 1254 or DDT in these assays. These data suggest that principles contained in Melissa Officinalis may block the binding of TSH to its receptor by acting both on the hormone and the receptor itself, while DDT and Aroclor 1254 affect cAMP production mainly at post-receptor step. In conclusion, we have developed a set of in vitro assays that allow investigation into the effect of thyroid disruptors on the TSH-mediated activation of the cAMP cascade. These assays may be useful to identify the mechanism of action of thyroid disruptors, coming beside and supporting animal studies or epidemiological surveys.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14759065     DOI: 10.1007/BF03348190

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 2.  TSH receptor and disease.

Authors:  M Tonacchera; J Van Sande; J Parma; L Duprez; F Cetani; S Costagliola; J E Dumont; G Vassart
Journal:  Clin Endocrinol (Oxf)       Date:  1996-06       Impact factor: 3.478

Review 3.  Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays.

Authors:  T Zacharewski
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

4.  Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

Authors:  L Chiovato; P Vitti; G Bendinelli; F Santini; E Fiore; A Capaccioli; M Tonacchera; C Mammoli; M Ludgate; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

5.  Histological investigations on the thyroid glands of marine mammals (Phoca vitulina, Phocoena phocoena) and the possible implications of marine pollution.

Authors:  U Schumacher; S Zahler; H P Horny; G Heidemann; K Skirnisson; U Welsch
Journal:  J Wildl Dis       Date:  1993-01       Impact factor: 1.535

Review 6.  Effects of environmental synthetic chemicals on thyroid function.

Authors:  F Brucker-Davis
Journal:  Thyroid       Date:  1998-09       Impact factor: 6.568

7.  Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.

Authors:  P Vitti; W A Valente; F S Ambesi-Impiombato; G F Fenzi; A Pinchera; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

8.  Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.

Authors:  M Auf'mkolk; J C Ingbar; S M Amir; H Winterhoff; H Sourgens; R D Hesch; S H Ingbar
Journal:  Endocrinology       Date:  1984-08       Impact factor: 4.736

Review 9.  Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks.

Authors:  Vladimir Turusov; Valery Rakitsky; Lorenzo Tomatis
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

Review 10.  Clues from wildlife to create an assay for thyroid system disruption.

Authors:  Theo Colborn
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

View more
  16 in total

1.  Assault on the thyroid by xenobiotics: another attack on G-protein coupled.

Authors:  S Benvenga
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

Review 2.  The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT).

Authors:  M Rossi; A R Taddei; I Fasciani; R Maggio; F Giorgi
Journal:  J Endocrinol Invest       Date:  2017-06-21       Impact factor: 4.256

Review 3.  Allosteric modulators of glycoprotein hormone receptors: discovery and therapeutic potential.

Authors:  Brian J Arey
Journal:  Endocrine       Date:  2008-10-28       Impact factor: 3.633

4.  Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.

Authors:  P Agretti; A Dimida; G De Marco; E Ferrarini; J C Rodrìguez Gonzàlez; F Santini; P Vitti; A Pinchera; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

5.  Sustainability of a well-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt.

Authors:  F Azizi; L Mehran; R Sheikholeslam; A Ordookhani; M Naghavi; M Hedayati; M Padyab; P Mirmiran
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

6.  Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH.

Authors:  L Croce; F Coperchini; M Tonacchera; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-05-17       Impact factor: 4.256

7.  A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.

Authors:  Susanne Neumann; Wenwei Huang; Elena Eliseeva; Steve Titus; Craig J Thomas; Marvin C Gershengorn
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

8.  Cancer mortality among men occupationally exposed to dichlorodiphenyltrichloroethane.

Authors:  Pierluigi Cocco; Domenica Fadda; Beatrice Billai; Mario D'Atri; Massimo Melis; Aaron Blair
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

9.  Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.

Authors:  David Melzer; Neil Rice; Michael H Depledge; William E Henley; Tamara S Galloway
Journal:  Environ Health Perspect       Date:  2010-01-07       Impact factor: 9.031

10.  Endocrine disruptors and the thyroid gland--a combined in vitro and in vivo analysis of potential new biomarkers.

Authors:  Cornelia Schmutzler; Inka Gotthardt; Peter J Hofmann; Branislav Radovic; Gabor Kovacs; Luise Stemmler; Inga Nobis; Anja Bacinski; Birgit Mentrup; Petra Ambrugger; Annette Grüters; Ludwik K Malendowicz; Julie Christoffel; Hubertus Jarry; Dana Seidlovà-Wuttke; Wolfgang Wuttke; Josef Köhrle
Journal:  Environ Health Perspect       Date:  2007-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.